Sputum Inflammatory Cell-Based Classification of Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease

PLoS ONE

Volumn 8, Issue 5, 2013, Pages

  Gao, Peng ^a,c,d   Zhang, Jie ^a,c   He, Xiaoyan ^b,c   Hao, Yuqiu ^a,c   Wang, Ke ^a,c   Gibson, Peter G ^b,c  

^a THE SECOND HOSPITAL OF JILIN UNIVERSITY   (China)

^b JOHN HUNTER HOSPITAL   (Australia)

^c JILIN UNIVERSITY   (China)

^d Changchun Central Hospital   (China)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; GELATINASE B; INTERLEUKIN 6; SERUM AMYLOID A;

ADULT; ARTICLE; BACTERIAL INFECTION; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DEMOGRAPHY; DISEASE CLASSIFICATION; DISEASE EXACERBATION; EOSINOPHILIA; FEMALE; GRANULOCYTOSIS; HUMAN; HUMAN CELL; INFLAMMATORY CELL; LONGITUDINAL STUDY; LUNG FUNCTION; MAJOR CLINICAL STUDY; MALE; NEUTROPHILIA; PHENOTYPE; PNEUMONIA; PROTEIN BLOOD LEVEL; SCORING SYSTEM; SPUTUM ANALYSIS;

ACUTE DISEASE; AGED; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; EOSINOPHILS; FEMALE; GRANULOCYTES; HUMANS; INTERLEUKIN-6; MALE; MATRIX METALLOPROTEINASE 9; MIDDLE AGED; NEUTROPHILS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; SERUM AMYLOID A PROTEIN; SEVERITY OF ILLNESS INDEX; SPUTUM;

BACTERIA (MICROORGANISMS);

EID: 84878524805     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0057678     Document Type: Article

References (23)

1. Celli BR, MacNee W, (2004) Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper. Eur Respir J 23: 932-946.
2. D'silva L, Hassan N, Wang HY, Kjarsgaard M, Efthimiadis A, et al. (2011) Heterogeneity of bronchitis in airway diseases in tertiary care clinical practice. Can Respir J 18: 144-148.
3. Bafadhel M, McKenna S, Terry S, Mistry V, Reid C, et al. (2011) Acute Exacerbations of COPD: Identification of Biological Clusters and Their Biomarkers. Am J Respir Crit Care Med 184: 662-671.
4. Pizzichini E, Pizzichini MM, Gibson P, Parameswaran K, Gleich GJ, et al. (1998) Sputum eosinophilia predicts benefit from prednisone in smokers with chronic obstructive bronchitis. Am J Respir Crit Care Med 158: 1511-1517.
5. Confalonieri M, Mainardi E, Della Porta R, Bernorio S, Gandola L, et al. (1998) Inhaled corticosteroids reduce neutrophilic bronchial inflammation in patients with chronic obstructive pulmonary disease. Thorax 53: 583-585.
6. O'Donnell RA, Peebles C, Ward JA, Daraker A, Angco G, et al. (2004) Relationship between peripheral airway dysfunction, airway obstruction, and neutrophilic inflammation in COPD. Thorax 59: 837-842.
7. Cowburn AS, Condliffe AM, Farahi N, Summers C, Chilvers ER, (2008) Advances in neutrophil biology: clinical implications. Chest 134: 606-612.
8. Franciosi LG, Page CP, Celli BR, Cazzola M, Walker MJ, et al. (2006) Markers of disease severity in chronic obstructive pulmonary disease. Pulm Pharmacol Ther 19: 189-199.
9. Keatings VM, Collins PD, Scott DM, Barnes PJ, (1996) Differences in interleukin-8 and tumor necrosis factor-alpha in induced sputum from patients with chronic obstructive pulmonary disease or asthma. Am J Respir Crit Care Med 153: 530-534.
10. Bozinovski S, Hutchinson A, Thompson M, Macgregor L, Black J, et al. (2008) Serum amyloid A is a biomarker of acute exacerbations of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 177: 269-278.
11. American Thoracic Society (1995) Standardization of Spirometry, 1994 Update. Am J Respir Crit Care Med 152: 1107-1136.
12. Gao P, Gibson PG, Zhang J, He X, Hao Y, et al. (2012) The Safety of sputum induction in adults with acute exacerbation of COPD. Clin Respir J. In press. doi:10.1111/j.1752-699X.2012.00291.x.
13. King PT, Holdsworth SR, Freezer NJ, Villanueva E, Holmes PW, (2007) Microbiologic follow-up study in adult bronchiectasis. Respir Med 101: 1633-1638.
14. Bisgaare H, Zielen S, Garcia-Garcia ML, Johnston SL, Gilles L, et al. (2005) Montelukast reduces asthma exacerbations in 2-to 5 year old children with intermittent asthma. Am J Respir Crit Care Med 171: 315-322.
15. Celli BR, Cote CG, Marin JM, Casanova C, Montes de Oca M, et al. (2004) The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease. N Engl J Med 350: 1005-1012.
16. ATS Committee on Proficiency Standards for Clinical Pulmonary Function Laboratories (2002) ATS statement: guidelines for the six-minute walk test. Am J Respir Crit Care Med 166: 111-117.
17. Simpson JL, Scott R, Boyle MJ, Gibson PG, (2006) Inflammatory subtypes in asthma: assessment and identification using induced sputum. Respirology 11: 54-61.
18. Fireman E, Kraiem Z, Sade O, Greif J, Fireman Z, (2002) Induced sputum-retrieved matrix metalloproteinase 9 and tissue metalloproteinase inhibitor 1 in granulomatous diseases. Clin Exp Immunol 130: 331-337.
19. Pinto-Plata V, Toso J, Lee K, Park D, Bilello J, et al. (2007) Profiling serum biomarkers in patients with COPD: associations with clinical parameters. Thorax 62: 595-601.
20. Mannino DM, Ford ES, Redd SC, (2003) Obstructive and restrictive lung disease and markers of inflammation: data from the Third National Health and Nutrition Examination. Am J Med 114: 758-762.
21. Butorac-Petanjek B, Parnham MJ, Popovic-Grle S, (2010) Antibiotic therapy for exacerbations of chronic obstructive pulmonary disease (COPD). J Chemother 22: 291-297.
22. Berim I, Sethi S, (2011) The benefits of long-term systemic antimicrobial therapy in chronic obstructive pulmonary disease. Ther Adv Respir Dis 5: 207-216.
23. Saetta M, Di Stefano A, Maestrelli P, Turato G, Ruggieri MP, et al. (1994) Airway eosinophilia in chronic bronchitis during exacerbations. Am J Respir Crit Care Med 150: 1646-1652.